Does GILTERITINIB Cause C-reactive protein increased? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of C-reactive protein increased have been filed in association with GILTERITINIB (Xospata). This represents 0.6% of all adverse event reports for GILTERITINIB.
22
Reports of C-reactive protein increased with GILTERITINIB
0.6%
of all GILTERITINIB reports
9
Deaths
14
Hospitalizations
How Dangerous Is C-reactive protein increased From GILTERITINIB?
Of the 22 reports, 9 (40.9%) resulted in death, 14 (63.6%) required hospitalization, and 2 (9.1%) were considered life-threatening.
Is C-reactive protein increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GILTERITINIB. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does GILTERITINIB Cause?
Acute myeloid leukaemia (366)
Febrile neutropenia (346)
Off label use (334)
Platelet count decreased (327)
Pneumonia (302)
Myelosuppression (300)
Pyrexia (281)
Death (206)
Product use issue (189)
Hepatic function abnormal (181)
What Other Drugs Cause C-reactive protein increased?
METHOTREXATE (5,999)
ADALIMUMAB (4,579)
RITUXIMAB (4,060)
ETANERCEPT (3,922)
TOCILIZUMAB (3,719)
INFLIXIMAB (3,621)
LEFLUNOMIDE (3,574)
HYDROXYCHLOROQUINE (3,552)
ABATACEPT (3,451)
SULFASALAZINE (3,096)
Which GILTERITINIB Alternatives Have Lower C-reactive protein increased Risk?
GILTERITINIB vs GIMERACIL\OTERACIL\TEGAFUR
GILTERITINIB vs GINKGO
GILTERITINIB vs GIVINOSTAT
GILTERITINIB vs GIVOSIRAN
GILTERITINIB vs GLASDEGIB